CGM Category Update: Clinical Outcomes, New Technologies, Therapeutic Dosing and Patient Access
Course expires: 10/18/2019
Self-monitoring of blood glucose (SMBG) is a core component of a diabetic patient's management but only provides a measurement of blood glucose levels at a specific point in time, often missing trends, hyperglycemic or hypoglycemic excursions. HbA1c is even more limited and reports an average reading over 90 days; therefore incapable of alerting the patient of fluctuations in blood glucose at any point in time.
- Selection of an appropriate Continuous Glucose Monitoring (CGM) device is important because improvements in accuracy and reliability are ongoing. RT-CGM is one cornerstone of optimal glycemic control. Each varies; relying on different sensing technology and requiring the traditional finger-stick for confirmation of alerts.
- The Mean Absolute Relative Difference (MARD) between sensor readings and reference glucose levels can vary by as much as 20% with worrisome discrepancies in the hypoglycemic range. But new generation devices have significantly improved MARD measurements. These devices have shorter lag times and improvements in accuracy. Many physicians are lacking the appropriate level of knowledge to employ CGM as part of their practices.
- Significant improvements in accuracy of CGM sensors and device algorithms have made CGM-based treatment decisions a current reality. This program will evaluate the clinical application of CGM in diabetes management decisions and the importance of various aspects of CGM to guide optimal treatment, regardless of insulin mode of administration.
At the conclusion of this activity, participants should be better able to:
- Recognize the role of CGM and its clinical benefit for patients using multiple daily injections.
- Employ real-time insulin dosing methods using CGM information to make more informed diabetes management decisions.
- Identify therapeutic CGM as a unique category, defined by Medicare, as CGM that does not require fingersticks to confirm diabetes management decisions; review the clinical study that proves CGM dosing is safe and efficacious.
- Primary Care Physicians
- Nurse Practitioners
- Certified Diabetes Educators
- Other healthcare professionals interested in the management of diabetes